Peter Tam Email & Phone Number

Peter is a pharmaceutical executive with over 25 years of drug development experience. Previously, he served as President and COO of Quadriga Biosciences where he managed the company’s operations, leading the development of the company’s lead compound from IND-enabling studies, CMC manufacturing, IND-filing with the FDA, and the initiation of a first-in-patient study. Prior to Quadriga, Peter served as President and a member of the Board of Directors of VIVUS Inc. Under his leadership, the company successfully developed four drugs from inception and obtained four consecutive NDA approvals. Peter built the company’s R&D pipeline through licensing and acquisition, built and led R&D teams (regulatory, clinical, and CMC), created and developed the company’s patent portfolio, and collaborated with the FDA, corporate partners, and stakeholders to ensure the successful development of the company's products. He helped raise over $500M in corporate financing during his 20-year tenure at VIVUS (1993-2012). He has extensive management experience in drug development, corporate/business development, senior executive leadership, and board experience in the biopharmaceutical industry. Prior to VIVUS, he held various research and development roles at Genentech and XOMA corporation in the areas of inflammation, infectious disease and critical care medicine.Peter received his BSc in Chemistry from University of California, Berkeley, and his MBA from Leavey School of Business at Santa Clara University. Peter has multiple issued patents and patent applications to his name and serves as a strategic advisor for and board member of Quadriga Biosciences.

Listed skills include Pharmaceutical Industry, Drug Development, Biotechnology, Clinical Development, and 27 others.